Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9578 posts found.

Illumina building

Illumina forms spin-off to develop cancer detection test

January 14, 2016 Research and Development Cancer, Illumina, cancer detection, gene sequencing, liquid biospy, oncology

Global gene sequencing company Illumina has won over $100 million in investment from high-profile investors, to create a company “to …
News
Baxalta logo

Baxalta’s Enbrel biosimilar measures up in late-stage study

January 13, 2016 Research and Development Amgen, Baxalta, Enbrel, Pfizer, biosimilar, etanercept, rheumatoid arthritis

Having emerged from its mega-merger deal with Shire, Baxalta is back on its drug development day job – and has …
News
Keytruda image

BioLineRx to test lead candidate with MSD’s Keytruda in pancreatic cancer

January 13, 2016 Research and Development MSD, immunotherapy, keytruda, pembrolizumab

Israeli biopharma company BioLineRx has announced a collaboration with MSD on a Phase II study investigating its lead oncology candidate, …
News
Obama_SOTU

Big pharma joins President Obama’s cancer ‘moonshot’

January 13, 2016 Research and Development Amgen, Cancer, Celgene, National Immunotherapy Coalition, President Barack Obama, US, moonshot

Celgene and Amgen are among the large biopharma companies that have agreed to join the National Immunotherapy Coalition (NIC), a …
News
dr_robert_califf_image_via_duke_university_school_of_medicine

Senate panel approves Dr Robert Califf as FDA commissioner

January 13, 2016 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Dr Robert Califf, FDA, FDA commissioner, Senate

A senate panel has approved president Obama’s nominee Dr Robert Califf to lead the FDA by a clear majority, although …
Appointment
Takeda reception

Takeda and enGene partner to develop gastro drugs

January 13, 2016 Research and Development Takeda

Takeda is teaming up with Canadian biotech enGene to develop novel therapies for specialty gastrointestinal (GI) diseases, using enGene’s ‘gene …
News
medimmune_logo_on_building

MedImmune and UCSF team up to research RAI treatments

January 13, 2016 Research and Development MedImmune, Precision Medicine, University of California San Francisco, autoimmunity

AstraZeneca’s biologics R&D arm MedImmune and the University of California, San Francisco (UCSF) have announced a new research collaboration focused …
News
MSD logo

MSD to acquire Scottish firm IOmet Pharma

January 12, 2016 Research and Development, Sales and Marketing IOMet Pharma, MSD, Merck, Scotland, acquisitions, immuno-oncology, mergers, oncology

US pharma company MSD is to buy Edinburgh based IOMet Pharma to expand its existing R&D programme, exploring the development …
News
a

AstraZeneca and MedImmune in oncology research deals

January 12, 2016 Manufacturing and Production, Research and Development AstraZeneca, Incyte, MedImmune, Moderna Therapeutics

AstraZeneca and its biologics arm MedImmune are launching new agreements with partner companies, to develop new targets for cancer, and …
News
mark_alles_celgene

Mark Alles is new chief executive of Celgene

January 12, 2016 Manufacturing and Production, Research and Development, Sales and Marketing Celgene, Mark Alles

Celgene president and chief operating officer Mike Alles has been promoted to the top job after an executive restructure at …
Appointment
DMD

The Pharmafocus debate: Can ultra-orphan drugs be made cheaper?

January 12, 2016 Manufacturing and Production, Research and Development, Sales and Marketing Drug pricing, Duchenne Muscular Dystrophy, Translarne, access to medicines, ataluren, muscular dystrophy, rare disease, ultra orphan drugs, ultra-orphan drugs

The recent reimbursement wrangle between PTC Therapeutics and NICE, the UK healthcare watchdog, has once again raised difficult questions about …
Feature
Roche building

Roche snaps up Tensha Therapeutics for up to $535m

January 12, 2016 Manufacturing and Production, Research and Development Roche, Tensha Therapeutics

Roche has acquired Tensha Therapeutics, a privately-held company based in Cambridge, Massachusetts for up to $535 million.The deal that gives …
News
AbbVie logo

AbbVie tests new hepatitis C drug in Phase III trials

January 11, 2016 Research and Development AbbVie, clinical trials, hepatitis C, phase III

AbbVie has announced it has begun six global Phase III trials of its once-daily, ribavirin-free investigational hepatitis C virus regimen, …
News

AbbVie begins late stage trials of rheumatoid arthritis drug

January 11, 2016 Manufacturing and Production, Research and Development, Sales and Marketing ABT-494, AbbVie, F-star, JAK-1 inhibitor, rheumatoid arthritis

AbbVie has begun a large phase III clinical trial programme for its next-generation rheumatoid arthritis (RA) treatment ABT-494, which the …
News
Elias Zerhouni

Sanofi seals double oncology research deals

January 11, 2016 Research and Development, Sales and Marketing Sanofi, Warp Drive Bio, antibodies, collaboration, immuno-oncology, research

Sanofi has signed two separate research agreements for €1.2 billion, which will give the French firm licensing rights to potential …
News
The Gateway to Local Adoption Series

Latest content

Just – Evotec given Gates Foundation grant to increase global biotherapeutics access

January 8, 2026

Johnson & Johnson submits robotic surgical system for De Novo classification

January 8, 2026

EA Pharma announces phase 3 trial for new schizophrenia treatment in Japan

January 7, 2026

Eleva appoints Erich Rajkovic as Chief Business Officer

January 7, 2026

MedPharm announces US FDA inspection of North Carolina manufacturing facility

January 6, 2026